Recurrent Bladder Carcinoma

2

Review clinical trials related to Recurrent Bladder Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer

This phase II trial is being done to develop and test a healthy eating program to reduce cancer recurrence (cancer that has come back after a period of improvement) and/or progression (cancer that is growing, spreading, or getting worse) in patients with non-muscle invasive bladder cancer (NMIBC). Researchers want to better understand how incorporating more cruciferous vegetables in the diet may reduce the risk of cancer recurrence or progression in men and women who were diagnosed with early-stage bladder cancer and compare whether extending the program can further improve bladder cancer outcomes. POW-R Health is a behavioral dietary intervention designed to modestly increase cruciferous vegetable (cruciferae) intake in patients. Cruciferous vegetables, such as cabbage, kale and broccoli, arugula, contain phytochemicals known as isothiocyanates (ITCs). Dietary ITCs exert potent anticancer activities against bladder cancer and can be rapidly metabolized, delivered to the bladder, and concentrated in the urine. Participating in the healthy eating program may reduce bladder cancer recurrence or progression in NMIBC survivors.

Participants needed: 344
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Roswell Park Cancer InstituteUpdated: May 8, 2026Locations: 1
Eligibility criteria

English speaking [+6]

Participants who had chemotherapy or radiotherapy within 4 weeks (6 weeks for ni... [+9]

Status: Recruiting

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

This study collects and studies tissue and blood samples from patients with prostate or bladder/urothelial cancer that has recurred (come back) at or near the same place as the original (primary) tumor or has spread to other parts of the body. Studying samples of blood and tissue samples from patients with prostate or bladder/urothelial cancer in the laboratory may help doctors learn more about new biomarkers, potential drug targets, and resistance developing in response to treatment. It may also help doctors find better ways to treat the cancer.

Participants needed: 1,500
Trial details
Age: 18+Biological sex: MaleType: ObservationalSponsor: University of WashingtonUpdated: Jan 15, 2026Locations: 1
Eligibility criteria

Patients with localized and/or metastatic bladder/urothelial or prostate cancer... [+9]

Patients unable to stop chronic anticoagulation with warfarin or Lovenox for les... [+2]